Abstract
Nodal status is a sensitive prognostic indicator in breast cancer. Axillary metastases may be an indication for neoadjuvant systemic therapy. The aims of this study were to compare pathologic response rates to neoadjuvant chemotherapy (NAC) in the breast and axilla across different molecular subtypes of breast cancer and to compare the predictive value of axillary assessment before and after chemotherapy in determining final nodal status in this cohort of patients.
| Original language | English (Ireland) |
|---|---|
| Pages (from-to) | 20-25 |
| Number of pages | 6 |
| Journal | Cancer |
| Volume | 14 |
| Issue number | 1 |
| DOIs | |
| Publication status | Published - 1 Oct 2013 |
Keywords
- Axilla
- Breast cancer
- HER2
- Neoadjuvant chemotherapy
- Pathologic response
Authors (Note for portal: view the doc link for the full list of authors)
- Authors
- McVeigh TP, Al-Azawi D, Kearney DE, Malone C, Sweeney KJ, Barry K, McLaughlin R, Keane M, Kerin MJ
- McVeigh, TP,Al-Azawi, D,Kearney, DE,Malone, C,Sweeney, KJ,Barry, K,McLaughlin, R,Keane, M,Kerin, MJ
